Skip to content

Clinical trials

Phase 2/3 trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Country / region: South Korea Clear all

245 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20063
20078
20088
20097
201017
201115
201212
201312
201410
201511
201613
20176
201820
20198
202013
202112
202218
20238
202412
202516
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed107
Recruiting42
Terminated35
Unknown status32
Active, not recruiting26
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chonbuk National University Hospital17
Seoul National University Hospital13
Bristol-Myers Squibb11
Seoul National University Bundang Hospital7
AbbVie6
Janssen Research & Development, LLC6
Pfizer6
Samsung Medical Center6
Asan Medical Center5
AstraZeneca5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung13
Neoplasms9
Colitis, Ulcerative8
Neoplasm Metastasis8
Recurrence7
Stomach Neoplasms7
COVID-196
Lung Neoplasms6
Alzheimer Disease5
Breast Neoplasms5

Trials

Showing 1 to 25 of 245. Each trial links to its page on Pharma Observatory.

145 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.